Get started
Author

M. Schuster

Pulmonary Embolism in Pregnant Patients: A Survey of Practices and Policies for CT Pulmonary Angiography
2003 · M. E. Schuster, J. E. Fishman, et al. · American Journal of Roentgenology · 69
Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants
2019 · Matthew Wu, Michael Schuster, et al. · Journal of Clinical and Translational Hepatology · 57
PDF
Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized, double-blind safety and efficacy trial.
2010 · J. R. Rigas, M. Schuster, et al. · Journal of Clinical Oncology · 47
Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.
2005 · J.F. San Miguel, P. Richardson, et al. · Blood · 47
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee
2023 · Kevin P. Robb, Jacques Galipeau, et al. · Cytotherapy · 40
PDF
Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.
2005 · Paul Richardson, P. Sonneveld, et al. · Blood · 38
ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.
2010 · M. Schuster, J. R. Rigas, et al. · Journal of Clinical Oncology · 30
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients
2000 · AF List, R Maziarz, et al. · Bone Marrow Transplantation · 25
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment
2016 · Usama Gergis, Emil Kuriakose, et al. · Clinical Lymphoma Myeloma & Leukemia · 22
Effectiveness of Recombinant Human Erythropoietin Therapy in Myelodysplastic Syndromes
2009 · J.W. Adamson, M. Schuster, et al. · Acta Haematologica · 21
Bortezomib Demonstrates Superior Efficacy to High-Dose Dexamethasone in Relapsed Multiple Myeloma: Final Report of the APEX Study.
2004 · Paul Richardson, P. Sonneveld, et al. · Blood · 17
Hematologic Profiles in the Phase 3 APEX Trial.
2005 · Sagar Lonial, P. Richardson, et al. · Blood · 16
A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2–01)
2004 · H. Loibner, H. Eckert, et al. · Journal of Clinical Oncology · 16
Health-related quality of life (HRQL) associated with bortezomib compared with high-dose dexamethasone in relapsed multiple myeloma (MM): Results from APEX study
2005 · S. J. Lee, P. G. Richardson, et al. · Journal of Clinical Oncology · 7
Mesenchymal stem cell therapy improves pulmonary function and exercise tolerance in patients with chronic obstructive pulmonary disease (copd) and high baseline inflammation
2020 · J. Hayes, M. Schuster, et al. · Cytotherapy · 4
306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)
2007 · P. Kebriaei, L. Isola, et al. · Transplantation and Cellular Therapy · 3
Works count: 16
Citation count: 459
H-index: 13
I10-index: 13
Year
Topic
Type